MRM
Income statement / Annual
Last year (2024), MEDIROM Healthcare Technologies Inc.'s total revenue was $8.30 B,
an increase of 21.55% from the previous year.
In 2024, MEDIROM Healthcare Technologies Inc.'s net income was $148.76 M.
See MEDIROM Healthcare Technologies Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$8.30 B |
$6.83 B |
$6.95 B |
$5.41 B |
$3.34 B |
$3.91 B |
$3.43 B |
| Cost of Revenue |
$6.05 B
|
$5.26 B
|
$5.05 B
|
$3.99 B
|
$2.91 B
|
$2.96 B
|
$2.48 B
|
| Gross Profit |
$2.25 B
|
$1.57 B
|
$1.90 B
|
$1.42 B
|
$428.95 M
|
$950.76 M
|
$956.87 M
|
| Gross Profit Ratio |
0.27
|
0.23
|
0.27
|
0.26
|
0.13
|
0.24
|
0.28
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$2.09 B
|
$1.80 B
|
$1.67 B
|
$1.68 B
|
$976.08 M
|
$793.95 M
|
$771.61 M
|
| Selling & Marketing Expenses |
$155.36 M
|
$162.03 M
|
$135.13 M
|
$130.96 M
|
$92.46 M
|
$77.91 M
|
$71.21 M
|
| Selling, General & Administrative Expenses |
$2.24 B
|
$1.96 B
|
$1.81 B
|
$1.81 B
|
$1.07 B
|
$871.86 M
|
$842.82 M
|
| Other Expenses |
$22.87 M
|
$0.00
|
$0.00
|
$75.21 M
|
$106.50 M
|
$33.35 M
|
$0.00
|
| Operating Expenses |
$2.26 B
|
$1.96 B
|
$1.81 B
|
$1.89 B
|
$1.18 B
|
$905.21 M
|
$850.61 M
|
| Cost And Expenses |
$8.32 B
|
$7.22 B
|
$6.86 B
|
$5.88 B
|
$4.09 B
|
$3.86 B
|
$3.33 B
|
| Interest Income |
$8.00 K
|
$1.11 M
|
$6.07 M
|
$839.00 K
|
$1.33 M
|
$1.34 M
|
$785.00 K
|
| Interest Expense |
$49.75 M
|
$36.87 M
|
$9.80 M
|
$11.95 M
|
$13.23 M
|
$13.59 M
|
$15.49 M
|
| Depreciation & Amortization |
$290.04 M
|
$252.60 M
|
$184.06 M
|
$126.24 M
|
$62.29 M
|
$46.17 M
|
$44.27 M
|
| EBITDA |
$387.50 M |
$310.09 M |
$373.63 M |
-$276.29 M |
-$551.17 M |
$125.07 M |
$158.31 M |
| EBITDA Ratio |
0.05
|
0.05
|
0.05
|
-0.05
|
-0.16
|
0.03
|
0.05
|
| Operating Income Ratio |
-0
|
-0.06
|
0.01
|
-0.09
|
-0.22
|
0.02
|
0.03
|
| Total Other Income/Expenses Net |
$65.82 M
|
$412.20 M
|
$82.81 M
|
$56.11 M
|
$119.40 M
|
-$1.05 M
|
-$22.48 M
|
| Income Before Tax |
$47.71 M
|
$20.62 M
|
$179.77 M
|
-$414.48 M
|
-$626.69 M
|
$33.30 M
|
$91.56 M
|
| Income Before Tax Ratio |
0.01
|
0
|
0.03
|
-0.08
|
-0.19
|
0.01
|
0.03
|
| Income Tax Expense |
-$90.48 M
|
-$94.43 M
|
$30.81 M
|
$576.25 M
|
-$87.52 M
|
$15.96 M
|
$25.25 M
|
| Net Income |
$148.76 M
|
$115.05 M
|
$148.97 M
|
-$990.73 M
|
-$539.17 M
|
$17.34 M
|
$66.31 M
|
| Net Income Ratio |
0.02
|
0.02
|
0.02
|
-0.18
|
-0.16
|
0
|
0.02
|
| EPS |
29.13 |
23.64 |
30.54 |
-203.13 |
-133.97 |
4.63 |
18.06 |
| EPS Diluted |
28.52 |
22.27 |
27.23 |
-203.13 |
-133.97 |
4.06 |
14.04 |
| Weighted Average Shares Out |
$5.11 M
|
$5.17 M
|
$5.47 M
|
$4.88 M
|
$4.02 M
|
$4.27 M
|
$4.72 M
|
| Weighted Average Shares Out Diluted |
$5.85 M
|
$5.17 M
|
$5.47 M
|
$4.88 M
|
$4.02 M
|
$4.27 M
|
$4.72 M
|
| Link |
|
|
|
|
|
|
|
